Confluent IPO Presentation Deck

GAAP to Non-GAAP Reconciliations (in thousands, except percentages) Total revenue Operating expenses on a GAAP basis Less: Stock-based compensation expense Less: Employer taxes on employee stock transactions Non-GAAP Operating expenses Non-GAAP Operating expenses as a % of total revenue Total revenue Research and development (R&D) expense on a GAAP basis Less: Stock-based compensation expense Less: Employer taxes on employee stock transactions Non-GAAP R&D expense Non-GAAP R&D expense as a % of total revenue FY'19 $149,805 $198,544 16,462 105 $181,977 127% FY'19 $149,805 $58,090 6,268 20 $51,802 35% FY'20 $236,577 $394,276 139,024 495 $254,757 108% FY'20 $236,577 $105,399 33,755 81 $71,563 30% Q1'20 $50,904 $66,474 5,639 75 $60,760 119% Q1'20 $50,904 $19,742 2,046 9 $17,687 35% Q1'21 $77,028 $98,334 11,834 263 $86,237 112% Q1'21 $77,028 $24,313 3,511 121 $20,681 27% 55

View entire presentation